Related Articles Spread of OXA 48 producing Klebsiella pneumoniae among COVID 19 infected patients The storm after the storm J Infect Public Health 2020 Dec 03 14 1 50 52 Authors Garc a Meni o I Forcelledo L Rosete Y Garc a Prieto E Escudero D Fern ndez J Abstract The impact of secondary infections by multidrug resistant bacteria in COVID 19 infected patients has yet to be evaluated Here we report the clinical and molecular features of an outbreak of seven patients carrying CTX M 15 and OXA 48 producing Klebsiella pneumoniae belonging to ST326 during COVID 19 pandemic in an ICU in northern Spain Those patients were admitted to beds close to each other two of them developed ventilator associated pneumonia VAP one exhibited primary bacteremia and the remaining four were considered to be colonized None of them was colonized prior to admission to the ICU an all except one of those who developed VAP were discharged Hydroxychloroquine and lopinavir ritonavir were administered to all of them as COVID 19 therapy and additionally three of them received tocilizumab and corticosteroids respectively Reusing of personal protective equipment due to its initial shortage relaxation in infection control measures and negative pressure air in ICU rooms recommended for the protection of health care workers HCWs could have contributed to this outbreak Maximization of infection control measures is essential to avoid secondary infections by MDR bacteria in COVID infected patients PMID 33341484 PubMed as supplied by publisher